Mercedes Mayos

Mercedes Mayos

Respiratory Department, Hospital De La Santa Creu I Sant Pau, Universitat Autònoma De Barcelona, Spain.

Direct Impact

Concepts for which Mercedes Mayos has direct influence:

hypoventilation syndrome
cpap ohs
obese osahs
airway pressure
invasive ventilation
performed variables

External impact

Concepts related to the work of other authors for which Mercedes Mayos has influence:

alglucosidase alfa
antibody titer
infantile pompe
therapeutic protein
replacement therapy
crossreactive immunologic
endogenous acid

Prominent publications by Mercedes Mayos

KOL-Index: 28 Late onset Pompe disease (LOPD) is a genetic disorder characterized by slowly progressive skeletal and respiratory muscle weakness. Symptomatic patients are treated with enzyme replacement therapy (ERT) with alglucosidase alpha (rhGAA). Although most of ERT treated patients develop antibodies against rhGAA, their influence on clinical progression is not completely known. We studied the ...
Known for
Quantitative Muscle | Antibodies Groups | Rhgaa Treated | Fat Fraction
KOL-Index: 2 Main objective:To describe clinical and functional characteristics of the obese hypoventilating patient; to study the relation between the obesity-hypoventilation syndrome (OHS) and the obstructive sleep apnea hypopnea syndrome (OSAHS). In the second stage of the study, to assess patient response to non-invasive mechanical ventilation (NIV) and continuous positive airway pressure (CPAP), and ...
Known for
Arterial Gases | Conventional Polysomnography | Pulse Oximetry | Sleep Clinic

Respiratory Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain.

© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172